C26H43LiO9
506.6 g/mol
APIWarning
Lithium 9-(((2E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)oxan-2-yl)-3-methylbut-2-enoyl)oxy)nonanoate
CAS73346-79-9
Category
API
Compound Class
Natural Product
Primary Use
Pharmaceutical Raw Material
This compound is a lithium salt form of a complex polyfunctional molecule used as an antibacterial active pharmaceutical ingredient. It features a long-chain carboxylic acid ester linked to a substituted tetrahydropyran ring and an epoxide moiety, with multiple alcohol and ether groups.
Antibacterial active pharmaceutical ingredient for pharmaceutical manufacturing
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 73346-79-9
Related Compounds
StrongSame Parent
Mupirocin calcium hydrate
CAS115074-43-6
pharmaceutical raw material
ApplicationSame Use
Sarafloxacin hydrochloride
CAS91296-87-6
pharmaceutical raw material
ReferenceSame Category
Bupivacaine hydrochloride hydrate
CAS73360-54-0
pharmaceutical raw material
ReferenceSame Category
19-norandrostenedione
CAS734-32-7
pharmaceutical raw material
ReferenceSame Category
Bifendate
CAS73536-69-3
pharmaceutical raw material
ReferenceSame Category
Ceftazidime dihydrochloride
CAS73547-70-3
pharmaceutical raw material
Referencestereoisomer of
Mupirocin
CAS12650-69-0
pharmaceutical raw material
Safety Reference
Warning
H317May cause an allergic skin reaction
Identifiers
IUPAC Name
lithium 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate
InChIKey
XFIKMPRBSORKQP-JATHGWPISA-M
SMILES
[Li+].C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)[O-])/C)[C@H](C)O
Synonyms (16)
- Mupirocin lithium, British Pharmacopoeia (BP)
- Mupirocin lithium, European Pharmacopoeia (EP)
- Mupirocin lithium, United States Pharmacopeia (USP)
- BRL-4910A (lithium)
- BRL-4910A;Pseudomonic acid
- Lithium mupirocin
- Mupirocin lithium CRS
- mupirocin lithium